Researchers discover treatable cause of severe anemia associated with a cancer therapy

drug approval expired 95% Health

Researchers at Mount Sinai Tisch Cancer Center identify a treatable folate deficiency causing severe anemia in some cancer patients receiving PARP inhibitors. Routine folic acid screening could reduce hospitalizations and treatment interruptions.

๐Ÿ‡ฌ๐Ÿ‡ง Location: Isle of Man — Sources: 6 — First seen: Last seen:
anemia cancer therapy folate deficiency PARP inhibitors Mount Sinai

Linked Entities

Mount Sinai Tisch Cancer Center

organization involved

PARP inhibitors

organization involved

NHS

organization involved ๐Ÿ‡ฌ๐Ÿ‡ง

England

location involved ๐Ÿ‡ฎ๐Ÿ‡ณ

Wales

location involved ๐Ÿ‡ฌ๐Ÿ‡ง

Nobby Stiles

person involved

Manchester United

organization involved ๐Ÿ‡ช๐Ÿ‡ธ

1966 World Cup

organization involved

Ederson

person involved

Atalanta

organization involved ๐Ÿ‡ฎ๐Ÿ‡น

The Daily Mail

organization involved

Contributing Articles